Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-22-000548
Filing Date
2022-10-13
Accepted
2022-10-13 16:01:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 logicbio.htm SC 13G 67449
  Complete submission text file 0000935836-22-000548.txt   68970
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Subject) CIK: 0001664106 (see all company filings)

EIN.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90696 | Film No.: 221309131
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277
Business Address 225 AVENUE I STE 205 REDONDO BEACH CA 90277 9174461561
Beryl Capital Management LLC (Filed by) CIK: 0001719307 (see all company filings)

EIN.: 474641111 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G